ENTITY
Hugel Inc

Hugel Inc (145020 KS)

48
Analysis
Health CareSouth Korea
Hugel, Inc. is a Bio-pharmaceutical company that focuses on developing beauty/cosmetics related products. The Company's main products include botulinum toxin and fillers.
more
Refresh
bullishHanon Systems
22 Dec 2021 06:17

Korea M&A Recap in 2021 - A Leapfrog Year

2021 has been a leapfrog year in terms of major M&As in Korea. Some of the largest M&A deals in 2022 could include Hanon Systems, Bodyfriend,...

Logo
315 Views
Share
bearishBNC Korea
29 Oct 2021 22:50

BNC Korea (256840 KS): Oral COVID-19 Treatment No More Remains a Catalyst

In-licensed oral COVID-19 treatment no longer remains a catalyst after competitor's encouraging clinical trial results. Other oral treatments are...

Logo
109 Views
Share
bearishHugel Inc
15 Aug 2021 05:44

The Fight to Acquire Hugel - GS Group Led Consortium or Goldman Sachs Led Consortium?

The fight to acquire Hugel Inc (145020 KS) is now finally down to between the GS Group led consortium and the Goldman Sachs led consortium.

Logo
406 Views
Share
bearishHugel Inc
29 Jun 2020 18:11

Hugel Placement: A 5.2% Block Deal Sale

After the market close today, it was reported that BK Medical Group’s Chairman Dr. Kim Byung-Gun and Dr. BK Corp will sell their 5.2% stake...

Logo
298 Views
Share
28 Mar 2019 07:36

Daewoong: Entering "Botox World"

Daewoong Pharmaceutical Co (069620 KS) has traded up over the past year in anticipation of the launch of its botulinum toxin product Jeuveau in the...

Share
x